Phibro Animal Health PAHC Proceeds From Issuance Of Other Long Term Debt

Proceeds From Issuance Of Other Long Term Debt at other companies

Compass Minerals InternationalCMP

——

Other financials

Income statement

See full

Revenue$383.5M+10.3%

Gross profit$125.7M+20.2%

Operating income$44.7M+33.2%

Net income$24.0M+15.1%

EPS (diluted)$0.59+15.7%

Balance sheet

See full

Cash & equivalents$54.9M-9.0%

Total debt$32.3M+27.8%

Total equity$361.8M+36.0%

Total assets$1.4B+9.7%

Cash flow

See full

Operating cash flow$16.2M-62.4%

CapEx$15.3M+97.7%

Free cash flow$890.0K-97.5%

Valuation

See full

Market cap$1.27B+31.4%

Enterprise value$1.25B+33.9%

P/E13.4×-17.1×

P/S0.9×0.0×

Profitability

See full

Gross margin32.5%+0.9pp

Operating margin12%+4.0pp

Net margin6.3%+3.7pp

FCF margin0.9%-3.3pp

Returns & leverage

See full

Return on equity30.3%+18.5pp

Debt / equity0.1×0.0×

Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt.

The official record: Phibro Animal Health’s 10-Q, filed February 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's proceeds from issuance of other long term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Phibro Animal Health's proceeds from issuance of other long term debt?: Phibro Animal Health (PAHC) reported proceeds from issuance of other long term debt of $350M in Q4 2024.